Clinical Aspects of Pharmaceutical Portfolio Management

Frederic (Rick) Sax (), Raymond A. Huml () and Judith Ng-Cashin ()
Additional contact information
Frederic (Rick) Sax: Quintiles Transnational Corp.
Raymond A. Huml: Quintiles Transnational Corp.
Judith Ng-Cashin: Quintiles Transnational Corp.

Chapter Chapter 2 in Optimization of Pharmaceutical R&D Programs and Portfolios, 2015, pp 19-33 from Springer

Abstract: Abstract This chapter examines the clinical aspects of pharmaceutical portfolio decision-making – a key driver of shareholder value – from the perspective of an Executive Committee reporting on portfolio strategy to a Board of Directors. Areas that are particularly important for shareholder value include a thorough evaluation of manufacturing and clinical drug development costs, commercial expectations, and the clinical risk/benefit assessment for each product. Other ways to evaluate risks associated with portfolio management include competitive intelligence, due diligence, patent protection and regulatory exclusivity. Portfolio managers must be aware of biases that can be inherent in portfolio decision-making, balancing those factors that may artificially increase or decrease the estimated probability of registration or commercial success. Complex tools, such as including adaptive design principles, and large data software tools can also be utilized to minimize and mitigate the risk and bias embraced by both the R&D and commercial factors

Keywords: Pharmaceutical portfolio management Pharmaceutical portfolio decision-making; Adaptive clinical trial design; Risk mitigation; Shareholder value (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-09075-7_2

Ordering information: This item can be ordered from
http://www.springer.com/9783319090757

DOI: 10.1007/978-3-319-09075-7_2

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().